NeoGenomics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
NeoGenomics, Inc. (NEO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $6.68 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-02-17
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $6.68M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $3.52M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $6.62M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $9.23M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $6.68M 10-K · filed 2026-02-17 |
| 2024-12-31 | $3.52M 10-K · filed 2025-02-18 |
| 2023-12-31 | $6.62M 10-K · filed 2024-02-20 |
| 2022-12-31 | $9.23M 10-K · filed 2023-02-24 |
| 2021-12-31 | $9.75M 10-K · filed 2022-02-25 |
| 2021-09-30 | $10.31M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $8.04M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $7.15M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $7.12M 10-K · filed 2021-02-25 |
| 2020-09-30 | $7.66M 10-Q · filed 2020-10-29 |
| 2019-12-31 | $5.09M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |